Literature DB >> 12207155

Annualized incidence and spectrum of illness from an outbreak investigation of Bell's palsy.

A M Morris1, S L Deeks, M D Hill, G Midroni, W C Goldstein, T Mazzulli, R Davidson, S G Squires, T Marrie, A McGeer, D E Low.   

Abstract

BACKGROUND: There are limited clinical and epidemiological data on patients diagnosed with Bell's palsy. While investigating an apparent clustering of Bell's palsy, we sought to characterize the spectrum of illness in patients with this diagnosis.
METHODS: A telephone survey of persons with idiopathic facial (Bell's) palsy in the Greater Toronto Area (GTA, population = 4.99 million) and Nova Scotia (population = 0.93 million) from August 1 to November 15, 1997 collected information on subject demographics, neurological symptoms, constitutional symptoms, medical investigation and management. Information regarding potential risks for exposure to infectious agents, past medical history, and family history of Bell's palsy was also collected. Subjects with other secondary causes of facial palsy were excluded.
RESULTS: In the GTA and Nova Scotia, 222 and 36 patients were diagnosed with idiopathic facial (Bell's) palsy, respectively. The crude annualized incidence of Bell's palsy was 15.2 and 13.1 per 100,000 population in the GTA and Nova Scotia, respectively. There was no temporal or geographical clustering, and symptomatology did not differ significantly between the two samples. The mean age was 45 years, with 55% of subjects being female. The most common symptoms accompanying Bell's palsy were increased tearing (63%), pain in or around the ear (63%), and taste abnormalities (52%). A significant number of patients reported neurological symptoms not attributable to the facial nerve.
CONCLUSION: No clustering of cases of Bell's palsy was observed to support an infectious etiology for the condition. Misdiagnosis of the etiology of facial weakness is common. Patients diagnosed with Bell's palsy have a variety of neurological symptoms, many of which cannot be attributed to a facial nerve disorder. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12207155     DOI: 10.1159/000065645

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  22 in total

1.  [Guillain-Barré syndrome with dysphagia after frontal sinusitis].

Authors:  A K Haug; V Rothhammer; E Q Scherer; A C Pickhard
Journal:  HNO       Date:  2013-01       Impact factor: 1.284

2.  New Predictive Parameters of Bell's Palsy: Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio.

Authors:  Doğan Atan; Aykut İkincioğulları; Sabri Köseoğlu; Kürşat Murat Özcan; Mehmet Ali Çetin; Serdar Ensari; Hüseyin Dere
Journal:  Balkan Med J       Date:  2015-04-01       Impact factor: 2.021

3.  Concurrent pityriasis rosea and Bell's palsy.

Authors:  Vanessa Voss; Adam Mattox; Mary Guo
Journal:  BMJ Case Rep       Date:  2017-01-23

4.  Peripheral facial palsy as an initial symptom of Lyme neuroborreliosis in an Austrian endemic area.

Authors:  Wolfgang Kindler; Hubert Wolf; Katrin Thier; Stefan Oberndorfer
Journal:  Wien Klin Wochenschr       Date:  2015-01-10       Impact factor: 1.704

5.  Facial nerve palsy: providing eye comfort and cosmesis.

Authors:  Adel H Alsuhaibani
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

6.  Potential misdiagnoses of Bell's palsy in the emergency department.

Authors:  Jahan Fahimi; Babak B Navi; Hooman Kamel
Journal:  Ann Emerg Med       Date:  2013-07-25       Impact factor: 5.721

7.  Not So Benign Bell's Palsy: Malignant Peripheral Nerve Sheath Tumor of the Facial Nerve Involving the Temporal Bone.

Authors:  Christopher N Nguyen; Niharika Mallepally; Jules R Tabilona; Lee B Lu
Journal:  J Gen Intern Med       Date:  2021-01-19       Impact factor: 5.128

8.  Epidemiology of Bell's palsy in an Italian Health District: incidence and case-control study.

Authors:  S Monini; A I Lazzarino; C Iacolucci; A Buffoni; M Barbara
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-08       Impact factor: 2.124

9.  Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy).

Authors:  Daniel Bremell; Lars Hagberg
Journal:  BMC Infect Dis       Date:  2011-08-10       Impact factor: 3.090

10.  Impact of clinical trial findings on Bell's palsy management in general practice in the UK 2001-2012: interrupted time series regression analysis.

Authors:  Daniel R Morales; Peter T Donnan; Fergus Daly; Tjeerd Van Staa; Frank M Sullivan
Journal:  BMJ Open       Date:  2013-07-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.